A study on Antibiotic Resistance: An Analysis of Molecular Mechanisms and Therapeutic Implications

Year : 2026 | Volume : 03 | Issue : 01 | Page : 9 21
    By

    Kazi Kutubuddin,

  • Heena Shaikh,

  1. Professor, BMIT, Solapur, Maharashtra, India
  2. Professor, BMIT, Solapur, Maharashtra, India

Abstract

Antibiotic resistance (AR) represents one of the most critical existential threats to global public health, rapidly eroding the efficacy of established antimicrobial therapies and portending a return to the pre-antibiotic era. This analysis explores the intricate molecular landscape defining this crisis, focusing specifically on the primary mechanisms of action (MoA) utilized by major antibiotic classes—including cell wall inhibitors, protein synthesis inhibitors, and nucleic acid synthesis inhibitors—and the corresponding, diverse mechanisms of resistance (MoR) evolved by pathogenic bacteria. The core MoR identified involve: (1) Enzymatic Inactivation, notably achieved through the widespread proliferation of $beta$-lactamases; (2) Target Site Modification, structurally altering critical binding sites (e.g., PBP2a in MRSA); and (3) Reduced Intracellular Concentration, mediated by enhanced efflux pump activity or decreased membrane permeability. These MoR are often encoded on mobile genetic elements, facilitating rapid horizontal transfer across species. Understanding the precise interplay between MoA and MoR is paramount, as current drug discovery efforts struggle to keep pace with the velocity of bacterial adaptation. The imperative is clear: a radical paradigm shift toward non- traditional therapeutics and resistance-breaking strategies is urgently required to preserve the foundation of modern medicine.

Keywords: Antibiotics, Antibiotic resistance, Enzymatic inactivation, Target site modification, intercellular concentration

[This article belongs to International Journal of Antibiotics ]

How to cite this article:
Kazi Kutubuddin, Heena Shaikh. A study on Antibiotic Resistance: An Analysis of Molecular Mechanisms and Therapeutic Implications. International Journal of Antibiotics. 2026; 03(01):9-21.
How to cite this URL:
Kazi Kutubuddin, Heena Shaikh. A study on Antibiotic Resistance: An Analysis of Molecular Mechanisms and Therapeutic Implications. International Journal of Antibiotics. 2026; 03(01):9-21. Available from: https://journals.stmjournals.com/ijab/article=2026/view=236724


References

  1. Habboush Y, Guzman N. Antibiotic resistance. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. 2022 Jun 23.
  2. Uddin TM, Chakraborty AJ, Khusro A, Zidan BR, Mitra S, Emran TB, et al. Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. J Infect Public Health. 2021;14(12):1750–1766.
  3. Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, Fischetti VA, et al. Alternatives to antibiotics—A pipeline portfolio review. Lancet Infect Dis. 2016;16(2):239–251.
  4. Czaplewski L, Bax R, Clokie M, Dawson M, Fairhead H, Fischetti VA, et al. Alternatives to antibiotics—A pipeline portfolio review. Lancet Infect Dis. 2016;16(2):239–251.
  5. Gould K. Antibiotics: From prehistory to the present day. J Antimicrob Chemother. 2016;71(3):572–575.
  6. Nicolaou KC, Rigol S. A brief history of antibiotics and select advances in their synthesis. J Antibiot. 2018;71(2):153–184.
  7. Pallasch TJ. Antibiotics: Past, present, and future. CDA J. 1986;14(5):65–68.
  8. Sköld O. Sulfonamide resistance: Mechanisms and trends. Drug Resist Updat. 2000;3(3):155–160.
  9. Tan SY, Tatsumura Y. Alexander Fleming (1881–1955): discoverer of penicillin. Singapore Med J. 2015;56(7):366.
  10. World Health Organization. Antibacterial agents in clinical development: An analysis of the antibacterial clinical development pipeline, including tuberculosis. Geneva: WHO; 2017.
  11. Frieri M, Kumar K, Boutin A. Antibiotic resistance. J Infect Public Health. 2017;10(4):369–378.
  12. Liyakat KK, Khadake SB, Chounde AB, Suryagan AA, HM M, Khadatare MR. AI-driven-IoT (AIIoT) based decision making system for high-blood pressure patient healthcare monitoring. In: Proc Int Conf Sustainable Communication Networks and Application (ICSCNA); 2024 Dec 11; IEEE. p. 96–102.
  13. Liyakat KK, Khadake SB, More PS, Shinde RJ, Kondubhairi KP, Kamble SS. AI-driven IoT based decision making for hepatitis diseases patient’s healthcare monitoring: KSK approach. In: Proc 7th Int Conf Intelligent Sustainable Systems (ICISS); 2025 Mar 12; IEEE. p. 256–263.
  14. Liyakat KK, Khadake SB, Galani K, Patil KB, Dhavale A, Sarik SD. AI-powered-IoT (AIIoT) based bridge health monitoring using sensor data for smart city management—A KSK approach. In: Proc 7th Int Conf Intelligent Sustainable Systems (ICISS); 2025 Mar 12; IEEE. p. 296–305.
  15. Liyakat KK, Khadake SB, Ingale BR, DD D, Sudake SS, Awatade MM. Kidney diseases patient healthcare monitoring using AI-driven-IoT (AIIoT)—A KSK1 approach. In: Proc 7th Int Conf Intelligent Sustainable Systems (ICISS); 2025 Mar 12; IEEE. p. 264–272.
  16. Liyakat KK, Khadake SB, Chounde AB, Suryagan AA, HM M, Khadatare MR. AI-driven-IoT (AIIoT) based decision making system for high-blood pressure patient healthcare monitoring. In: Proc Int Conf Sustainable Communication Networks and Application (ICSCNA); 2024 Dec 11; IEEE. p. 96–102.
Regular Issue Subscription Review Article
Volume 03
Issue 01
Received 28/10/2025
Accepted 14/11/2025
Published 20/01/2026
Publication Time 84 Days
74

Login


My IP

PlumX Metrics